Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2009, for Zeta Acquisition Corp. II (not Whitehawk Therapeutics, Inc., as indicated in the metadata). The registrant is a Delaware corporation organized as a "blank check" company and a shell company. Its primary objective is to investigate and acquire a target business to achieve long-term growth. The company has no specific business plan other than to merge with an unidentified company and has generated no revenues since its inception on November 16, 2007.
Key Financial Metrics
| Metric | Q1 2009 | Q1 2008 | Cumulative (Inception to Mar 31, 2009) |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Net Loss | $(3,405) | $(9,084) | $(52,005) |
| Cash and Cash Equivalents | $7,408 | $27,939 | $7,408 |
| Total Assets | $7,408 | $27,939 | $7,408 |
| Total Liabilities | $9,413 | $6,108 | $9,413 |
| Stockholders' Equity (Deficit) | $(2,005) | $1,400 | $(2,005) |
| Net Cash Used in Operating Activities | $(100) | $(11,334) | $(42,592) |
| Net Cash Provided by Financing Activities | $0 | $0 | $50,000 |
Capital Structure: 5,000,000 shares of common stock issued and outstanding as of May 15, 2009. No preferred stock issued.
Material Changes vs. Prior Period
- Liquidity Decline: Cash and cash equivalents decreased by $100 during the quarter, dropping from $7,508 at December 31, 2008, to $7,408 at March 31, 2009.
- Liability Increase: Current liabilities (accounts payable and accrued expenses) increased by $3,305, rising from $6,108 to $9,413.
- Equity Deficit: The company moved from a positive equity position of $1,400 to a deficit of $(2,005) due to the net loss for the quarter.
- Expense Reduction: Net loss for the quarter decreased significantly from $9,084 in Q1 2008 to $3,405 in Q1 2009, primarily due to lower formation costs in the current period compared to the prior year.
Outlook, Risks, and Management Commentary
Going Concern: Management explicitly states that the company's ability to continue as a going concern is dependent upon its ability to obtain additional financing and consummate a business combination. The financial statements do not include adjustments that might be necessary if the company cannot continue as a going concern.
Liquidity and Funding: The company has no revenue and relies on capital investment or loans from related parties (stockholders and management) to fund operations. There is no assurance that continued funding will be available at reasonable terms.
Business Plan: The company intends to identify a target business for acquisition within the next 12 months. It may target financially unstable companies, early-stage entities, or established businesses seeking a public market. No specific target has been identified.
Risks: Significant risks include the inability to find a suitable acquisition target, the potential for the target to be financially unstable, and the high probability of failure to consummate a transaction, which could result in the liquidation of the company.
Investor Verification Checklist
- Capital Adequacy: Verify if the company has secured additional funding beyond the $7,408 cash on hand to sustain operations for the next 12 months.
- Related Party Dependence: Confirm the extent of reliance on stockholders and officers for loans and office space (provided at no cost).
- Liability Status: Investigate the nature of the $9,413 in accrued expenses and accounts payable to ensure no defaults are imminent.
- Acquisition Progress: Assess whether any definitive agreements or serious discussions regarding a business combination have occurred since the filing date.
- Shell Company Status: Acknowledge the high risk associated with investing in a "blank check" company with no operating history or assets other than cash.